Posts in category

In Depth


Debbie Rigby takes a look at the latest in research news Prescribing aspirin to older people – where is the line between cardiovascular benefit and upper gastrointestinal bleeding risk? In …

… then it’s time to think again, write C Raina MacIntyre, UNSW Sydney; Brendan Crabb, Burnet Institute; and Nancy Baxter, the University of Melbourne COVID is an exceptional disease and …

Debbie Rigby rounds up the latest in research news Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality In this large population study, patients prescribed benzodiazepines/Z drugs and weak opioids …

Millions of Australians still haven’t had their COVID boosters. What message could convince them now? The Halton independent review of Australia’s COVID vaccine and treatment procurement has been handed to the …

Here’s how to identify medicines that may be potential targets for deprescribing, writes Amy Page Polypharmacy is a growing public health concern and medicines safety is a vital health issue …

Debbie Rigby rounds up the latest in research news COPD‐X Australian guidelines for the diagnosis and management of COPD This summary of the updated COPD-X guidelines highlights the importance of …

Most pharmacy owners are busy everyday in their practices, but are they missing out on the chance to plan for business success, asks John Thornett? At the time I write …

Did COVID harm my immune system? Am I now at risk of other infectious diseases? Lara Herrero from Griffith University investigates So you’ve had COVID and have now recovered. You …

Pharmacists can have a significant role to play in helping people manage shingles, writes Louis Roller Shingles (also known as herpes zoster) is a viral infection caused by a reactivation of the varicella-zoster …

When the technology gods collude to ruin your day the impact can send shock waves through the workplace. Who are these gods and why do they interfere with an already …

Debbie Rigby rounds up the latest in research news SGLT-2 inhibitors in patients with heart failure A comprehensive meta-analysis of five randomised controlled trials has concluded that SGLT2 inhibitors reduce …

A strong pharmacy market can be frustrating for potential buyers. Natalie Sirianni has some tips to help your chances of success  During the last two years through the COVID-19 pandemic, …